Hospital News and Research

RSS

Bacteria and fungi may protect against asthma in rural children: Study

Children who grow up on farms are less likely to suffer from asthma than other rural children. An international team of researchers including Dr. Markus Ege and Professor Erika von Mutius at Ludwig-Maximilians-Universitaet has published a large-scale study that now indicates that this may be due to differences in the spectrum of microbes the two groups are likely to encounter.

24 Feb 2011

New research: Spinal fluid proteins can differentiate nPTLS from Chronic Fatigue Syndrome

Patients who suffer from Neurologic Post Treatment Lyme disease and those with the Chronic Fatigue Syndrome report similar symptoms. However unique proteins discovered in spinal fluid can distinguish those two groups from one another and also from people in normal health, according to new research conducted by a team led by Steven E. Schutzer, MD, of the University of Medicine and Dentistry of New Jersey - New Jersey Medical School, and Richard D. Smith, Ph.D., of Pacific Northwest National Laboratory.

24 Feb 2011

Oncolytics completes patient enrollment in REOLYSIN trial to treat metastatic colorectal cancer

Oncolytics Biotech Inc. announced today that enrollment has been completed in a U.K. translational clinical trial investigating intravenous administration of REOLYSIN in patients with metastatic colorectal cancer prior to surgical resection of liver metastases.

23 Feb 2011

California researchers receive InHealth grant to evaluate device-intensive procedures

The Institute for Health Technology Studies has awarded a $263,000 grant to a research team at the University of California, Berkeley, to identify and analyze the strategies that hospital systems employ to evaluate and purchase implantable medical devices for cardiac, spinal, and orthopedic procedures.

23 Feb 2011

PCI Biotech completes patient inclusion in PC-A11 phase I/II study to treat cancer

PCI Biotech the Norwegian biopharmaceutical company, reported today that it has completed the inclusion of patients in its phase I/II study of its lead candidate PC-A11 in cancer patients.

23 Feb 2011

Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure

Trevena Inc., the leader in G-protein coupled receptor biased ligand drug discovery, today announced the initiation of a Phase 2a clinical trial with its lead program, TRV120027, a beta-arrestin biased angiotensin II type 1 receptor ligand, the first biased ligand designed to treat patients with acute heart failure.

23 Feb 2011

Australia’s top scientist takes on top job

Today, the man who is known for one of Australia’s greatest medical achievements – the development of a cervical cancer vaccine – has been appointed as Chief Executive Officer of the Translational Research Institute (TRI) in Brisbane, Queensland.

23 Feb 2011

Biological pathways in PTSD revealed: Study

Up to 20% of the population exposed to a horror of a war, trauma or abuse may go on to develop post-traumatic stress disorder. PTSD, as it is better known, is a debilitating psychiatric disorder marked by flashbacks and nightmares. Till date the biological basis for PTSD was unclear. But a new study offers clues about why some people rebound from horrific events while others relive them, and may lead to predictive tests and even treatments.

23 Feb 2011

Norgine, Tranzyme commence dosing in ulimorelin Phase 3 study for restoring GI function after surgery

Tranzyme Pharma and Norgine B.V., have initiated dosing of ulimorelin in the first of two, Phase 3 pivotal studies - ULISES. Ulimorelin is Tranzyme's intravenous promotility agent in development for the management of postoperative ileus in hospital and acute care settings.

23 Feb 2011

Pretreatment with FDA-approved drug allows successful pregnancies in radiation-exposed rhesus monkeys

A strategy developed by Massachusetts General Hospital (MGH) researchers to shield the ovaries of female mammals from the damaging effects of radiation and chemotherapy has passed an important milestone. A collaborative study with investigators from Oregon Health and Sciences University (OHSU), published online in the journal Fertility and Sterility, reports that brief preexposure of the ovaries to an FDA-approved agent called FTY720 preserved the fertility of female rhesus monkeys exposed to potentially lethal doses of radiation.

23 Feb 2011

Dual lab tests accurately predict vein graft blood clots in patients during CABG

A team of heart experts at Johns Hopkins has found that dual lab tests of blood clotting factors accurately predict the patients whose blood vessels, in particular veins implanted to restore blood flow to the heart during coronary artery bypass grafting, are more likely to fail or become clogged within six months.

23 Feb 2011

ASGE announces 35 new honorees under Endoscopy Unit Recognition Program

The American Society for Gastrointestinal Endoscopy (ASGE) has recognized 35 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States. The ASGE Endoscopy Unit Recognition Program honors endoscopy units that follow the ASGE guidelines on privileging, quality assurance, endoscopy reprocessing and CDC infection control guidelines. To date, 307 endoscopy units have been recognized by ASGE.

23 Feb 2011

Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Journal of Clinical Oncology

Amgen today announced the publication of results from a pivotal Phase 3 study of 1,776 advanced cancer patients with different types of solid tumors or multiple myeloma, which compared XGEVA to Zometa in preventing skeletal-related events.

23 Feb 2011

Roundup: Calif. hospital's unusual Medicare billing; Tenn. gastric bypass; Mass. Acos

Redding, where the Valley meets Cascade foothills, and Victorville, in the Mojave Desert, have little in common but an unusual statistic: In each city, a hospital has reported alarming rates of a Third World nutritional disorder among its Medicare patients. Kwashiorkor - a Ghanaian word for "weaning sickness" - is a severe protein deficiency that almost exclusively afflicts impoverished children in developing countries, especially during famines, experts say.

23 Feb 2011

Knocking out genes completely and exclusively in Natural Killer cells

Our immune systems contain three fundamentally different types of cell: B-cells, T-cells and the mysteriously named Natural Killer cells (NK cells), which are known to be involved in killing tumour cells and other infected cells. Experiments to investigate the function of NK cells have proven difficult to interpret because the interactions between the various components of the immune system make it almost impossible to isolate effects of individual cell types.

23 Feb 2011

UT Southwestern Medical Center launches new multidisciplinary abdominal wall surgery program

A 2002 auto accident started Rex Smith down a dark and difficult road. The collision perforated his colon, requiring multiple surgeries that subsequently weakened his abdominal muscles until they could no longer hold in internal organs.

23 Feb 2011

New study finds inadequate health literacy among paid caregivers of seniors

Paid caregivers make it possible for seniors to remain living in their homes. The problem, according to a new Northwestern Medicine study, is that more than one-third of caregivers had difficulty reading and understanding health-related information and directions. Sixty percent made errors when sorting medications into pillboxes.

23 Feb 2011

Biochemist receives STAC grant to find treatment for C. albicans infection in premature infants

A $200,000 grant from the Rhode Island Science and Technology Advisory Council is helping a Bryant University biochemist find a treatment for a fungal infection that is often lethal to premature infants.

23 Feb 2011

Nanoparticle therapy may improve survival after life-threatening blood loss

In an advance that could improve battlefield and trauma care, scientists at Albert Einstein College of Medicine of Yeshiva University have used tiny particles called nanoparticles to improve survival after life-threatening blood loss.

23 Feb 2011

New DNA technology to study cystic fibrosis 'superbug' during infection

The bacterium, called Pseudomonas aeruginosa, is the most common cause of persistent and fatal lung infections in cystic fibrosis patients. Scientists at Liverpool identified a particularly virulent strain of the bacteria that is transmissible between patients. The Liverpool Epidemic Strain (LES), referred to as a cystic fibrosis 'superbug', can cause aggressive infection and results in progressive lung decline.

23 Feb 2011

Hospital News and Research

Bacteria and fungi may protect against asthma in rural children: Study

New research: Spinal fluid proteins can differentiate nPTLS from Chronic Fatigue Syndrome

Oncolytics completes patient enrollment in REOLYSIN trial to treat metastatic colorectal cancer

California researchers receive InHealth grant to evaluate device-intensive procedures

PCI Biotech completes patient inclusion in PC-A11 phase I/II study to treat cancer

Trevena commences TRV120027 Phase 2a trial in patients with acute heart failure

Australia’s top scientist takes on top job

Biological pathways in PTSD revealed: Study

Norgine, Tranzyme commence dosing in ulimorelin Phase 3 study for restoring GI function after surgery

Pretreatment with FDA-approved drug allows successful pregnancies in radiation-exposed rhesus monkeys

Dual lab tests accurately predict vein graft blood clots in patients during CABG

ASGE announces 35 new honorees under Endoscopy Unit Recognition Program

Amgen announces publication of XGEVA Phase 3 study results against solid tumors in Journal of Clinical Oncology

Roundup: Calif. hospital's unusual Medicare billing; Tenn. gastric bypass; Mass. Acos

Knocking out genes completely and exclusively in Natural Killer cells

UT Southwestern Medical Center launches new multidisciplinary abdominal wall surgery program

New study finds inadequate health literacy among paid caregivers of seniors

Biochemist receives STAC grant to find treatment for C. albicans infection in premature infants

Nanoparticle therapy may improve survival after life-threatening blood loss

New DNA technology to study cystic fibrosis 'superbug' during infection

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News